Investment Rating - The investment rating for the company is "Buy" (maintained) [1][3]. Core Views - The company is actively expanding its market presence in Southeast Asia and the United States, with a notable increase in export orders from European clients [4]. - For the first three quarters of 2024, the company achieved a revenue of 575 million yuan, representing a year-on-year growth of 15%, and a net profit of 59.28 million yuan, also up by 15% year-on-year [3]. - The company forecasts a net profit increase of 55%-65% for 2023 [1]. Financial Performance Summary - Revenue for 2024 is projected to be 825 million yuan, with a year-on-year growth of 18.5% [6]. - The net profit for 2024 is estimated at 77 million yuan, with a year-on-year growth of 13.1% [6]. - The company’s gross margin is expected to be 19.7% in 2024, with a net margin of 9.4% [6]. - The earnings per share (EPS) for 2024 is projected to be 0.75 yuan, with a price-to-earnings (P/E) ratio of 17.6 times [6]. Market Expansion Efforts - The company is focusing on developing markets in Russia and Southeast Asia, where the growth rate is high and similar to the early development stage of the pet industry in China [4]. - There has been a significant increase in prepaid orders from overseas clients in Southeast Asia and India, with contract liabilities rising by 64.4% year-on-year [4]. - The company plans to leverage existing customer resources in the U.S. and enhance order acquisition through exhibitions and online platforms [4]. Marketing and Brand Promotion - The company has increased its sales expenses by 66.98% year-on-year to 27.18 million yuan for the first three quarters of 2024, focusing on both offline and online channels [5]. - The brand promotion strategy includes the operation of a Douyin IP "Da Lu and Si Si," which aims to enhance brand visibility through animated content related to pet behaviors and emotions [5].

路斯股份股价创出历史新高，截至9:55，该股上涨15.02%，股价报12.94元，成交量281.79万股，成交金 额3426.76万元，换手率3.01%，该股最新A股总市值达13.37亿元，该股A股流通市值12.11亿元。 证券时报•数据宝统计显示，路斯股份所属的农林牧渔行业，目前整体涨幅为0.97%，行业内，目前股价 上涨的有97只，涨停的有荃银高科、万向德农等3只。 股价下跌的有13只，跌幅居前的有晨光生物、国投中鲁、永顺生物等，跌幅分别为4.44%、1.73%、 1.65%。 两融数据显示，该股最新（10月25日）两融余额为116.63万元，其中，融资余额为116.63万元，近10日 增加37.81万元，环比增长47.97%。 公司发布的三季报数据显示，前三季度公司共实现营业收入5.75亿元，同比增长14.75%，实现净利润 5928.40万元，同比增长15.14%，基本每股收益为0.5700元，加权平均净资产收益率11.57%。 （数据宝）注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 智能盯盘股价异动、新高、历史新高、创新高、股价、大涨、上涨 ...

证券代码：832419 证券简称：路斯股份 公告编号：2024-076 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 山东路斯宠物食品股份有限公司 第五届监事会第十一次会议决议公告 会议应出席监事 3 人，出席和授权出席监事 3 人。 监事魏海涛先生因工作原因以通讯方式参与表决。 二、议案审议情况 （一）审议通过《关于 2024 年三季度报告的议案》 1.议案内容： 公司已编制 2024 年三季度报告，详见公司在北京证券交易所（www.bse.cn） 披露的《2024 年三季度报告》（公告编号：2024-077）。 （一）会议召开情况 5.会议主持人：韩金政先生 6.召开情况合法、合规、合章程性说明： 本次会议的召开符合《公司法》等法律法规及公司章程的规定。 （二）会议出席情况 监事会 2024 年 10 月 25 日 1.会议召开时间：2024 年 10 月 24 日 2.会议召开地点：公司会议室 3.会议召开方式：现场、通讯方式 4.发出监事会会议通知的时间和方式：2024 ...

证券代码：832419 证券简称：路斯股份 公告编号：2024-075 山东路斯宠物食品股份有限公司 第五届董事会第十二次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 会议应出席董事 7 人，出席和授权出席董事 7 人。 董事熊德斌、黄栋因工作原因以通讯方式参与表决。 二、议案审议情况 （一）审议通过《关于 2024 年三季度报告的议案》 1.议案内容： 公司已编制 2024 年三季度报告，详见公司在北京证券交易所（www.bse.cn） （一）会议召开情况 1.会议召开时间：2024 年 10 月 24 日 2.会议召开地点：公司会议室 3.会议召开方式：现场、通讯 4.发出董事会会议通知的时间和方式：2024 年 10 月 21 日以通讯方式发出 5.会议主持人：郭百礼先生 6.会议列席人员：监事 7.召开情况合法、合规、合章程性说明： 本次会议的召开符合《公司法》等法律法规及公司章程的规定。 （二）会议出席情况 披露的《2024 年三季度报告》（公告编号：2 ...

Financial Performance - Operating revenue for the first nine months of 2024 reached CNY 574,826,380.09, a 14.75% increase from CNY 500,929,294.59 in the same period of 2023[3] - Net profit attributable to shareholders for the first nine months of 2024 was CNY 59,284,013.76, reflecting a 15.14% increase from CNY 51,488,456.77 year-on-year[3] - In Q3 2024, operating revenue surged by 38.31% to CNY 223,696,960.20, compared to CNY 161,731,385.93 in Q3 2023[3] - Net profit attributable to shareholders in Q3 2024 was CNY 24,642,198.71, a remarkable 114.83% increase from CNY 11,470,473.46 in Q3 2023[3] - Total operating revenue for the first nine months of 2024 reached ¥574,826,380.09, an increase of 14.7% compared to ¥500,929,294.59 in the same period of 2023[23] - Net profit for the first nine months of 2024 was ¥60,453,104.34, representing a 15.5% increase from ¥52,538,786.83 in the same period of 2023[24] - The company achieved an operating profit of ¥69,507,513.03, up 13.8% from ¥61,239,034.16 year-over-year[24] - The total profit for the first nine months of 2024 was ¥68,851,993.36, an increase of 13.8% from ¥60,543,024.67 in the same period of 2023[24] - Total comprehensive income amounted to CNY 51,549,382.68, compared to CNY 41,680,270.04 in the previous period, reflecting a significant increase[26] Assets and Liabilities - Total assets increased by 12.09% to CNY 741,078,376.88 as of September 30, 2024, compared to CNY 661,173,453.68 at the end of 2023[3] - Accounts receivable rose by 58.04% to CNY 72,990,864.50, primarily due to increased export orders from major European clients[4] - The company’s construction in progress increased by 168.79% to CNY 44,406,889.18, driven by the development of irradiation projects and overseas pet food projects in Cambodia[4] - Contract liabilities grew by 64.40% to CNY 13,538,967.55, attributed to increased advance payments from overseas customers in Southeast Asia and India[4] - Total current assets increased to ¥391,830,619.60 from ¥369,608,343.57, marking an increase of approximately 5.3%[16] - Fixed assets grew to ¥237,572,290.80, up from ¥208,369,334.69, indicating an increase of about 13.98%[16] - Non-current assets totaled ¥349,247,757.28, an increase from ¥291,565,110.11, reflecting a growth of about 19.7%[18] - Current liabilities rose to ¥131,201,120.19 from ¥128,651,265.24, indicating a slight increase of 1.3%[18] - Total liabilities amounted to ¥160,912,441.31, compared to ¥164,882,797.28, showing a decrease of approximately 2.1%[18] - Shareholders' equity increased to ¥580,165,935.57 from ¥496,290,656.40, marking a growth of about 16.9%[18] Cash Flow - Cash flow from operating activities decreased by 43.91% to CNY 40,426,682.87 in the first nine months of 2024, down from CNY 72,070,817.95 in the same period of 2023[3] - Net cash flow from operating activities decreased to CNY 40,426,682.87 from CNY 72,070,817.95, a decline of about 43.9%[27] - Cash inflows from operating activities totaled CNY 602,279,739.62, up from CNY 550,487,680.90, representing a growth of approximately 9.5%[27] - Cash outflows for investing activities increased significantly to CNY 157,415,477.92 from CNY 89,421,903.69, indicating a rise of approximately 76.1%[28] - Net cash flow from investing activities was negative at CNY -98,525,947.27, worsening from CNY -44,263,813.11[28] - Cash inflows from financing activities rose to CNY 107,201,666.85, compared to CNY 15,000,000.00 in the previous period[28] - The net cash flow from financing activities was negative at CNY -12,743,017.20, compared to CNY -1,297,337.23 previously[28] - The ending balance of cash and cash equivalents decreased to CNY 102,567,650.44 from CNY 117,398,405.47, a decline of approximately 12.6%[28] Expenses and Income - Sales expenses increased by 66.98% to CNY 27,178,574.95, reflecting the company's intensified market development efforts[4] - Management expenses increased to ¥20,222,783.21, representing a 43.23% increase due to higher employee salaries and training costs[5] - Other income decreased by 52.89% to ¥1,330,101.44, primarily due to a reduction in government subsidies received[5] - Investment income fell by 91.43% to ¥141,432.88, with no related income from entrusted loans this period[5] - Credit impairment losses surged by 2,453.11% to -¥1,264,535.47, attributed to a significant increase in accounts receivable[5] - Asset impairment losses rose by 256.14% to -¥180,233.52, linked to trial production costs in the Cambodia project[5] - The company reported a profit margin of approximately 10.5% for the first nine months of 2024, compared to 10.5% in the same period of 2023[24] - The company’s financial expenses showed a net income of -¥5,924,275.27, compared to -¥6,625,242.21 in the previous year, indicating improved financial management[23] Shareholder Information - The total share capital at the end of the period was 103,346,400 shares, with 4,430 shareholders[7] - The company implemented a stock buyback plan, repurchasing 100,000 shares at a price of ¥3.35 per share, which is approximately 0.0967% of the total shares before the buyback[15] - The company has a stock incentive plan in place for senior management and key employees, with a total of 4,833,000 shares issued to 79 participants[14] Future Outlook - The company plans to expand its market presence and invest in new technologies to drive future growth[22]

证券代码：832419 证券简称：路斯股份 公告编号：2024-078 山东路斯宠物食品股份有限公司 关于控股子公司增资暨公司放弃优先认缴权的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 山东路斯宠物食品股份有限公司（以下简称"公司"）于 2024 年 10 月 24 日 召开第五届董事会第十二次会议，审议通过了《关于控股子公司卡尔露文（寿 光）供应链有限公司增资暨公司放弃优先认缴权的议案》，具体情况如下： 一、本次增资的基本情况 为提高公司控股子公司卡尔露文（寿光）供应链有限公司（以下简称"卡尔 露文"）的业务履约能力，卡尔露文拟增加注册资本 23 万元。基于公司未来发 展规划，公司拟放弃本次增资的优先认缴权，本次增资将由北京瀚海智云信息 科技有限公司全额认缴。本次增资后，公司持有卡尔露文的股权将由 51%下降 至 41.46%，卡尔露文将成为公司参股公司。本次增资完成前后，卡尔露文股权 结构如下： | 股东名称 | 增资前股权结构 | | 增资后股权结构 | | | --- | --- | ...

证券代码：832419 证券简称：路斯股份 公告编号：2024-074 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 山东路斯宠物食品股份有限公司股票解除限售公告 一、本次股票解除限售数量总额为 810,000 股，占公司总股本 0.7838%，可交易 时间为 2024 年 10 月 28 日。 二、本次股票解除限售的明细情况及原因 单位：股 | | | 是否为控 | | | | 本次解 | | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 董事、监 | | | 除限售 | | | | | 股股东、 | | | 本次解除 | | 尚未解除 | | | 股东姓名 | | 事、高级 | 本次解限 | | 股数占 | | | 序号 | | 实际控制 | | | 限售登记 | | 限售的股 | | | 或名称 | | 管理人员 | 售原因 | | 公司总 | | | | | 人或其一 | | | 股票数量 | | 票数量 | | | | 致 ...

证券代码：832419 证券简称：路斯股份 公告编号：2024-069 山东路斯宠物食品股份有限公司 关于回购注销部分限制性股票的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 一、 审议及表决情况 山东路斯宠物食品股份有限公司（以下简称"公司"）于 2024 年 10 月 15 日召开第 五届董事会第十一次会议、第五届监事会第十次会议，审议通过了《关于回购注销部分 限制性股票的议案》。上述议案已事先经公司第五届独立董事第四次专门会议审议通过， 且尚需提交公司股东大会审议。 二、 定向回购类型及依据 定向回购类型：股权激励计划限制性股票回购注销 定向回购依据： 根据《北京证券交易所上市公司持续监管指引第 4 号——股份回购》（以下简称"监 管指引第 4 号"）第四章第六十七条第二款规定："有下列情形之一的，上市公司可以根 据相关回购条款或有关规定向本所申请办理定向回购：……（二）上市公司出现股权激 励计划规定的应当回购注销限制性股票情形的，上市公司根据相关回购条款或有关规 定，回购激励对象所持股份； ...

证券代码：832419 证券简称：路斯股份 公告编号：2024-067 山东路斯宠物食品股份有限公司 第五届董事会第十一次会议决议公告 2.议案表决结果：同意 7 票；反对 0 票；弃权 0 票。 本议案已经公司第五届独立董事第四次专门会议审议通过。 3.回避表决情况： 本议案不涉及关联交易事项，不存在回避表决情形。 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 会议应出席董事 7 人，出席和授权出席董事 7 人。 董事熊德斌、黄栋因工作原因以通讯方式参与表决。 二、议案审议情况 （一）审议通过《关于回购注销部分限制性股票的议案》 1.议案内容： 鉴于公司 2020 年股权激励计划激励对象魏中民因离职不再具备激励对象资 （一）会议召开情况 1.会议召开时间：2024 年 10 月 15 日 2.会议召开地点：公司会议室 3.会议召开方式：现场、通讯方式 4.发出董事会会议通知的时间和方式：2024 年 10 月 10 日以通讯方式发出 5.会议主持人：郭百礼先生 6.会议列席人 ...

证券代码：832419 证券简称：路斯股份 公告编号：2024-071 山东路斯宠物食品股份有限公司 关于召开 2024 年第二次临时股东大会通知公告（提供网络投票） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开基本情况 （一）股东大会届次 本次会议为 2024 年第二次临时股东大会。 （二）召集人 本次股东大会的召集人为董事会。 （三）会议召开的合法性、合规性 本次会议的召开符合《公司法》等法律、法规及公司章程的有关规定，且不 需要相关部门批准。 （四）会议召开方式 本次会议采用现场投票和网络投票相结合方式召开。 同一表决权只能选择现场、网络中的一种。 （五）会议召开日期和时间 投资者首次登陆中国结算网站进行投票的，需要首先进行身份认证。请投资 者提前访问中国结算网上营业厅（网址：inv.chinaclear.cn）或中国结算官方微信公 众号（"中国结算营业厅"）进行注册，对相关证券账户开通中国结算网络服务功 能。具体方式请参见中国结算网站（网址：www.chinaclear.cn）" ...